On March 11, 2021, the Board of Directors of Sangamo Therapeutics, Inc. appointed Prathyusha Duraibabu as the company's principal financial officer with immediate effect. Ms. Duraibabu has served as the company's principal accounting officer since June 2019 and as the company's Vice President, Finance since March 2019 and continues to serve the company in these roles.